Arzu Ergen

4PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 15, 2022
The modulatory action of C-Vx substance on the immune system in COVID-19.

Ilhan Tahrali, Nilgun Akdeniz, Vuslat Yilmaz

|Aug 16, 2022
The inhibitory effect of betulinic acid on epithelial-mesenchymal transition pathway in renal cell carcinoma.

Merve Nur Ataş, Barış Ertuğrul, Elif Sinem İplik

|Jun 25, 2021
Levofloxacin might be safe to use for OSCC patients.

Levent Aydemir, Elif Sinem Iplik, Baris Ertugrul

|Apr 19, 2019
Irak-4 rs4251481 gene variant: as a risk factor on inflammatory bowel disease

Gonca Candan, Resul Kahraman, Arzu Ergen

Pageof 1